Key insights of the Clinical Practice Guidelines for the Management of Hypertension in China

In September 2024, 3 leading committees—the Chinese Society of Cardiology under the Chinese Medical Association, the Hypertension Committee of the Cross-Straits Medicine Exchange Association, and the Cardiovascular Disease Prevention and Rehabilitation Committee of the Chinese Association of Rehabilitation Medicine—jointly released the Clinical Practice Guidelines for the Management of Hypertension in China (hereinafter referred to as the “Guidelines”). These Guidelines address 44 key clinical issues closely related to the prevention and management of hypertension, offering a total of 98 evidence-based recommendations. This article highlights and provides an in-depth analysis of the 9 key insights from the Guidelines to assist physicians in better understanding its most critical content.